About Tripartite motif-containing protein 6
Tripartite motif-containing protein 6 (TRIM6) is a protein
from Homo sapiens identified by UniProt accession
Q9C030, 488 residues long.
MolForge cross-references it against 0 known binders and
34 disease associations.
Target properties
| Protein name | Tripartite motif-containing protein 6 |
| UniProt accession | Q9C030 |
| Gene | TRIM6 |
| Organism | Homo sapiens |
| Length | 488 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (34)
Diseases linked to this target (Open Targets).
- body height · score 0.23
- lung adenocarcinoma · score 0.07
- metabolite measurement · score 0.02
- cystatin C measurement · score 0.02
- blood phosphate measurement · score 0.02
- creatinine measurement · score 0.02
- ovarian carcinoma · score 0.02
- systemic lupus erythematosus · score 0.02
- neoplasm · score 0.02
- lymph node metastatic carcinoma · score 0.02
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9C030-F1 | alphafold | PREDICTED | 86.14 | — |
Amino-acid sequence (488 residues)
MTSPVLVDIR EEVTCPICLE LLTEPLSIDC GHSFCQACIT PNGRESVIGQ EGERSCPVCQ TSYQPGNLRP NRHLANIVRR LREVVLGPGK QLKAVLCADH GEKLQLFCQE DGKVICWLCE RSQEHRGHHT FLVEEVAQEY QEKFQESLKK LKNEEQEAEK LTAFIREKKT SWKNQMEPER CRIQTEFNQL RNILDRVEQR ELKKLEQEEK KGLRIIEEAE NDLVHQTQSL RELISDLERR CQGSTMELLQ DVSDVTERSE FWTLRKPEAL PTKLRSMFRA PDLKRMLRVC RELTDVQSYW VDVTLNPHTA NLNLVLAKNR RQVRFVGAKV SGPSCLEKHY DCSVLGSQHF SSGKHYWEVD VAKKTAWILG VCSNSLGPTF SFNHFAQNHS AYSRYQPQSG YWVIGLQHNH EYRAYEDSSP SLLLSMTVPP RRVGVFLDYE AGTVSFYNVT NHGFPIYTFS KYYFPTTLCP YFNPCNCVIP MTLRRPSS
Explore Tripartite motif-containing protein 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets